Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?

Current Opinion in Supportive and Palliative Care

Volumn 5, Issue 4, 2011, Pages 307-311

  Waterhouse, Esther ^a,b   Ahmad, Fawad ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b Leicestershire and Rutland Organisation for the Relief of Suffering   (United Kingdom)

Author keywords

Conversations; Deactivation; End of life; Implantable cardioverter defibrillators

Indexed keywords

ATTITUDE TO HEALTH; DECISION SUPPORT SYSTEM; DEFIBRILLATOR; DOCTOR PATIENT RELATION; HEALTH PERSONNEL ATTITUDE; HEART FAILURE; HUMAN; INTERPERSONAL COMMUNICATION; METHODOLOGY; PASSIVE EUTHANASIA; PSYCHOLOGICAL ASPECT; REVIEW; TERMINAL CARE;

ATTITUDE OF HEALTH PERSONNEL; COMMUNICATION; DECISION SUPPORT TECHNIQUES; DEFIBRILLATORS, IMPLANTABLE; EUTHANASIA, PASSIVE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEART FAILURE; HUMANS; PHYSICIAN-PATIENT RELATIONS; TERMINAL CARE;

EID: 84856924664     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e32834d2cce     Document Type: Review

References (23)

1. Kirkpatrick JN, Fields AV, Ferrari VA. Medical ethics and the art of cardiovascular medicine. Lancet 2010; 376:508-509. A clear and thought-provoking exposition on the ethical issues that clinicians in cardiology need to address as more technologies become available to them.
2. Lampert R, Hayes DL, Annas GJ, et al. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010; 7:1008-1026. This is a key position statement from experts across America, giving clear guidance as to the legal, ethical and practical issues of deactivating ICDs. It also covers similar issues arising from the deactivation of permanent pacemakers. As well as clarifying the legal and ethical issues, it gives guidance on communication issues and the practicalities of deactivation.
3. Padeletti L, Arnar DO, Boncinelli L, et al. EHRA expert consensus statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace 2010; 12:1480-1489. This article aims to help all those caring for patients with ICDs, who are reaching the end of life, in order to improve the patient dying process. It covers the topic comprehensively, with clear bullet points to summarize good practice.
4. Strachan PH, Carroll SL, de Laat S, et al. Patients' perspectives on end-of-life issues and implantable cardioverter defibrillators. J Palliat Care 2011; 27:6-11. Qualitative interviews with patients with ICD, most of whom had heart failure as defined by a low ejection fraction, revealed a focus on the prevention of sudden cardiac death, and a lack of thought about the implications of an ICD for death by other causes
5. Al-Khatib SM, Hellkamp A, Curtis J, et al. Nonevidence-based ICD implantations in the United States. JAMA 2011; 305:43-49.
6. Cutro R, Rich MW, Hauptman PJ. Device therapy in patients with heart failure and advanced age: Too much too late? Int J Cardiol 2011. [Epub ahead of print].
7. Swindle JP, Rich MW, McCann P, et al. Implantable cardiac device procedures in older patients: Use and in-hospital outcomes. Arch Intern Med 2010; 170:631-637.
8. Kramer DB, Kesselheim AS, Brock DW, Maisel WH. Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: A quantitative assessment. Heart Rhythm 2010; 7:1537-1542. This survey showed how uncomfortable doctors are with discussing deactivation of ICDs, and highlighted the need for further education and training.
9. Sherazi S, Daubert JP, Block RC, et al. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. Mayo Clin Proc 2008; 83:1139-1141.
10. Mueller PS, Jenkins SM, Bramstedt KA, Hayes DL. Deactivating implanted cardiac devices in terminally ill patients: Practices and attitudes. Pacing Clin Electrophysiol 2008; 31:560-568. (Pubitemid 351595284)
11. Marinskis G, van Erven L, EHRA Scientific Initiatives Committee. Deactivation of implanted cardioverter-defibrillators at the end of life: Results of the EHRA survey. Europace 2010; 12:1176-1177. This survey of clinicians in large European centres showed that, although clinicians claim to be comfortable with deactivating ICDs at the end of life, there is little consensus on how to do it and there is little routine discussion with patients about deactivation.
12. Kelley AS, Reid MC, Miller DH, et al. Implantable cardioverter- defibrillator deactivation at the end of life: A physician survey. Am Heart J 2009; 157:702.e1-708.e1.
13. Goldstein N, Carlson M, Livote E, Kutner JS. Brief communication: Management of implantable cardioverter-defibrillators in hospice - a nationwide survey. Ann Intern Med 2010; 152:296-299.
14. Kapa S, Mueller PS, Hayes DL, Asirvatham SJ. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: Results of a survey of medical and legal professionals and patients. Mayo Clin Proc 2010; 85:981-990. This study sent clinical vignettes to clinicians, lawyers and patients in order to examine attitudes toward ICD deactivation. The three groups did not always agree, but most agreed that patients who were terminally ill could have their ICD deactivated. There was some lack of understanding about the legality of deactivating pacemakers and ICDs.
15. Berger JT, Gorski M, Cohen T. Advance health planning and treatment preferences among recipients of implantable cardioverter defibrillators: An exploratory study. J Clin Ethics 2006; 17:72-78. (Pubitemid 43643945)
16. Goldstein NE, Mehta D, Siddiqui S, et al. That's like an act of suicide' patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med 2008; 23 (Suppl 1):7-12. (Pubitemid 350295388)
17. Kramer DB, Kesselheim AS, Salberg L, et al. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy. Am J Cardiol 2011; 107:1071-1075; e5. This article, although it studies a population with hypertrophic cardiomyopathy rather than heart failure, gives some important insights into the understanding of patients with ICDs. Many patients did not know whether deactivating an ICD was legal, and patients saw deactivation as morally different to withdrawing other lifeprolonging therapy.
18. Kaufman SR, Mueller PS, Ottenberg AL, Koenig BA. Ironic technology: Old age and the implantable cardioverter defibrillator in US healthcare. Soc Sci Med 2011; 72:6-14. This exploratory article looks at the use of ICDs in modern medicine and reflects on the way in which people die, considering whether they are forgoing sudden death in order to suffer a prolonged death.
19. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008; 359:1009-1017.
20. Goldstein NE, Mehta D, Teitelbaum E, et al. It's like crossing a bridge' complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life. J Gen Intern Med 2008; 23 (Suppl 1):2-6. (Pubitemid 350295386)
21. England R, England T, Coggon J. The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer. J Med Ethics 2007; 33:538-540.
22. Beauregard LA. Ethics in electrophysiology: A complaint from palliative care. Pacing Clin Electrophysiol 2010; 33:226-227.
23. Conelius J. A literature review: Advance directives and patients with implantable cardioverter defibrillators. J Am Acad Nurse Pract 2010; 22:250-255.